The Claim
Apigenin reduces the release of IL-6, IL-8, and ICAM-1 in vivo in mice exposed to compound 48/80, extending its anti-inflammatory effects from cellular models to a whole-animal system.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin decreases the production of IL-6, IL-8, and ICAM-1 in live mice exposed to compound 48/80, demonstrating anti-inflammatory activity beyond cell-based experiments.
See the scientific wording
Apigenin reduces the release of IL-6, IL-8, and ICAM-1 in vivo in mice exposed to compound 48/80, extending its anti-inflammatory effects from cellular models to a whole-animal system.
Apigenin blocks a specific stress signal in blood vessel cells, which stops those cells from releasing chemicals that attract immune cells and cause swelling. This reduces inflammation throughout the body.
What the research says
1 studyIn mice with an allergic reaction, apigenin lowered three key inflammation signals (IL-6, IL-8, ICAM-1), proving it works in a living body—not just in a dish.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.